J0737
HCPCSInj, clindamycin (baxter)
Official HCPCS Level II long descriptor
Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg
HCPCS Level II code J0737 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj, clindamycin (baxter)
Added to HCPCS: 2023-07-01
Nearby codes in J0
- J0713Inj ceftazidime per 500 mg
- J0714Ceftazidime and avibactam
- J0716Centruroides immune f(ab)
- J0717Certolizumab pegol inj 1mg
- J0720Chloramphenicol sodium injec
- J0725Chorionic gonadotropin/1000u
- J0735Clonidine hydrochloride
- J0736Inj, clindamycin phosp 300mg
- J0738Hiv prep, inj, lenacapavir
- J0739Hiv prep, inj, cabotegravir
- J0740Cidofovir injection
- J0741Inj, cabote rilpivir 2mg 3mg
- J0742Inj imip 4 cilas 4 releb 2mg
- J0743Cilastatin sodium injection
- J0744Ciprofloxacin iv
- J0745Inj codeine phosphate /30 mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.